Reprogramming the Tumor Oncobiosphere: Bioactive Nanohybrid Materials for Reversing Therapeutic Pseudo-Resistance

Area of Science:

• Oncology
• Systems Biology
• Nanotechnology

Background:

• Tumor resistance is a complex systems-level problem involving the tumor ecosystem.
• The
• oncobiosphere
• concept integrates cellular, molecular, and biophysical factors influencing treatment.
• Pseudoresistance can occur due to physical barriers and signaling, not just genetic mutations.

Purpose of the Study:

• To define the
• oncobiosphere
• as a framework for understanding tumor resistance.
• To explore how nanobiotechnology can overcome resistance by modulating the tumor microenvironment.
• To propose therapeutic resistance as a reversible ecological state.

Main Methods:

• Conceptual framework development defining the
• oncobiosphere
• .
• Review of signaling pathways (integrin-FAK, TGF-β, YAP/TAZ, STAT3, Wnt/β-catenin) involved in resistance.
• Exploration of nanobiotechnology applications (e.g., nanoniclosamide, ECM-targeting systems).

Main Results:

• The
• oncobiosphere
• framework highlights extrinsic feedback loops driving resistance.
• Key pathways promote ECM remodeling, desmoplasia, and impaired drug penetration, causing pseudoresistance.
• Nanomedicine offers potential to disrupt stromal dynamics and restore therapeutic accessibility.

Conclusions:

• Therapeutic resistance is an emergent property of the tumor's ecological state.
• Modulating the oncobiosphere offers a novel strategy for durable anticancer responses.
• Nanobiotechnology presents opportunities to overcome resistance by targeting the tumor microenvironment.